Precision Genomics Collaboratory News

Rana Gupta, PhD, W. David and Sarah W. Stedman Distinguished Professor in the School of Medicine  Tell us about your clinical, academic, or research interest and why you are passionate about this topic or area of focus.

Professor Svati H. Shah, MD, MHS, Cardiology Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases Tell us about your clinical, academic, or research interest and why you are passionate about this topic or area of focus.

This spring, five faculty members in the Precision Genomics Collaboratory have been awarded distinguished professorships. The new distinguished professors were honored at the annual distinguished professorship event on May 4.   In total, Duke University awarded distinguished professorships to 44 faculty members from seven Duke colleges and schools this year.   Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.   

Sequencing and Genomic Technologies Director, Devjanee (Devi) Swain Lenz, will be one of the invited panel speakers at the Festival of Genomics and Biodata conference

It’s an old story: Pathogen sickens humans. Humans create medicine. Pathogen evolves a way around the medicine. Humans are back to square one.

James White, PhD, Gurpreet Baht, PhD, and team show that biological age is fluid, and while it can age faster under stress, it can also be restored once those stressors are eliminated.

Duke Health researchers have identified the cause of an inherited metabolic disease common among people with Lumbee and other Native American heritage.

The Molecular Genomics Core in the Duke Molecular Physiology Institute (DMPI) has added a 10xGenomics in situ sequencing platform called Xenium. The new platform allows for single cell spatial resolution of gene expression and provides spatial context of targeted RNA profiles within tissues.

In December 1995, the work of over 40 researchers culminated with a landmark publication in Nature. The team had discovered a second breast cancer susceptibility gene: BRCA2. Their discovery revolutionized cancer research and screening in breast, ovarian, and prostate cancers and has impacted millions of people’s lives in the years since.

A national committee co-chaired by Duke Professor Charmaine Royal issued a report that emphasized the high stakes of ensuring that genetics research benefits all groups in society and mitigates harm.